OBJECTIVES: Shear wave elastography (SWE) is a promising adjunct to greyscale ultrasound in differentiating benign from malignant breast masses. The purpose of this study was to characterise breast cancers which are not stiff on quantitative SWE, to elucidate potential sources of error in clinical application of SWE to evaluation of breast masses. METHODS: Three hundred and two consecutive patients examined by SWE who underwent immediate surgery for breast cancer were included. Characteristics of 280 lesions with suspicious SWE values (mean stiffness >50 kPa) were compared with 22 lesions with benign SWE values (<50 kPa). Statistical significance of the differences was assessed using non-parametric goodness-of-fit tests. RESULTS: Pure ductal carcinoma in situ (DCIS) masses were more often soft on SWE than masses representing invasive breast cancer. Invasive cancers that were soft were more frequently: histological grade 1, tubular subtype, ≤10 mm invasive size and detected at screening mammography. No significant differences were found with respect to the presence of invasive lobular cancer, vascular invasion, hormone and HER-2 receptor status. Lymph node positivity was less common in soft cancers. CONCLUSION: Malignant breast masses classified as benign by quantitative SWE tend to have better prognostic features than those correctly classified as malignant. KEY POINTS: • Over 90 % of cancers assessable with ultrasound have a mean stiffness >50 kPa. • 'Soft' invasive cancers are frequently small (≤10 mm), low grade and screen-detected. • Pure DCIS masses are more often soft than invasive cancers (>40 %). • Large symptomatic masses are better evaluated with SWE than small clinically occult lesions. • When assessing small lesions, 'softness' should not raise the threshold for biopsy.
OBJECTIVES: Shear wave elastography (SWE) is a promising adjunct to greyscale ultrasound in differentiating benign from malignant breast masses. The purpose of this study was to characterise breast cancers which are not stiff on quantitative SWE, to elucidate potential sources of error in clinical application of SWE to evaluation of breast masses. METHODS: Three hundred and two consecutive patients examined by SWE who underwent immediate surgery for breast cancer were included. Characteristics of 280 lesions with suspicious SWE values (mean stiffness >50 kPa) were compared with 22 lesions with benign SWE values (<50 kPa). Statistical significance of the differences was assessed using non-parametric goodness-of-fit tests. RESULTS: Pure ductal carcinoma in situ (DCIS) masses were more often soft on SWE than masses representing invasive breast cancer. Invasive cancers that were soft were more frequently: histological grade 1, tubular subtype, ≤10 mm invasive size and detected at screening mammography. No significant differences were found with respect to the presence of invasive lobular cancer, vascular invasion, hormone and HER-2 receptor status. Lymph node positivity was less common in soft cancers. CONCLUSION: Malignant breast masses classified as benign by quantitative SWE tend to have better prognostic features than those correctly classified as malignant. KEY POINTS: • Over 90 % of cancers assessable with ultrasound have a mean stiffness >50 kPa. • 'Soft' invasive cancers are frequently small (≤10 mm), low grade and screen-detected. • Pure DCIS masses are more often soft than invasive cancers (>40 %). • Large symptomatic masses are better evaluated with SWE than small clinically occult lesions. • When assessing small lesions, 'softness' should not raise the threshold for biopsy.
Authors: Wendie A Berg; David O Cosgrove; Caroline J Doré; Fritz K W Schäfer; William E Svensson; Regina J Hooley; Ralf Ohlinger; Ellen B Mendelson; Catherine Balu-Maestro; Martina Locatelli; Christophe Tourasse; Barbara C Cavanaugh; Valérie Juhan; A Thomas Stavros; Anne Tardivon; Joel Gay; Jean-Pierre Henry; Claude Cohen-Bacrie Journal: Radiology Date: 2012-02 Impact factor: 11.105
Authors: Colin A Purdie; Lee B Jordan; Jean B McCullough; Sharon L Edwards; Joan Cunningham; Miriam Walsh; Andrew Grant; Norman Pratt; Alastair M Thompson Journal: Histopathology Date: 2010-05 Impact factor: 5.087
Authors: Jung Min Chang; Woo Kyung Moon; Nariya Cho; Ann Yi; Hye Ryoung Koo; Wonsik Han; Dong-Young Noh; Hyeong-Gon Moon; Seung Ja Kim Journal: Breast Cancer Res Treat Date: 2011-06-17 Impact factor: 4.872
Authors: Jung Min Chang; In Ae Park; Su Hyun Lee; Won Hwa Kim; Min Sun Bae; Hye Ryoung Koo; Ann Yi; Seung Ja Kim; Nariya Cho; Woo Kyung Moon Journal: Eur Radiol Date: 2013-05-15 Impact factor: 5.315
Authors: Andrew Evans; Patsy Whelehan; Kim Thomson; Denis McLean; Katrin Brauer; Colin Purdie; Lee Jordan; Lee Baker; Alastair Thompson Journal: Breast Cancer Res Date: 2010-12-01 Impact factor: 6.466
Authors: A Evans; P Whelehan; K Thomson; K Brauer; L Jordan; C Purdie; D McLean; L Baker; S Vinnicombe; A Thompson Journal: Br J Cancer Date: 2012-06-12 Impact factor: 7.640
Authors: Elisabetta Giannotti; Sarah Vinnicombe; Kim Thomson; Dennis McLean; Colin Purdie; Lee Jordan; Andy Evans Journal: Br J Radiol Date: 2016-03-23 Impact factor: 3.039
Authors: Wei Lin Ng; Kartini Rahmat; Farhana Fadzli; Faizatul Izza Rozalli; Mohammad Nazri Mohd-Shah; Patricia Ann Chandran; Caroline Judy Westerhout; Anushya Vijayananthan; Yang Faridah Abdul Aziz Journal: Medicine (Baltimore) Date: 2016-03 Impact factor: 1.889